
Collegium Pharmaceutical, Inc
COLLNasdaqCIK 1267565HealthcareFiscal year ends Dec 31
Reports and events: 194 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2017-11-0816:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-17-066982 |
| 2017-08-0916:16 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-17-050713 |
| 2017-08-0916:02 ET | 10-Q | Quarterly reportPeriod 2017-06-30 | 0001558370-17-006414 |
| 2017-05-3108:31 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-17-036401 |
| 2017-05-1016:06 ET | 10-Q | Quarterly reportPeriod 2017-03-31 | 0001558370-17-004119 |
| 2017-05-1016:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-17-031536 |
| 2017-04-1317:01 ET | DEF 14A | Proxy statementPeriod 2017-05-24 | 0001104659-17-023418 |
| 2017-03-1307:39 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-17-015965 |
| 2017-03-1017:18 ET | 10-K | Annual reportPeriod 2016-12-31 | 0001558370-17-001629 |
| 2017-03-0916:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-17-015487 |
| 2016-11-1016:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-16-156234 |
| 2016-11-1016:02 ET | 10-Q | Quarterly reportPeriod 2016-09-30 | 0001558370-16-009927 |
| 2016-10-2716:08 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-16-152585 |
| 2016-10-2516:01 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-16-151916 |
| 2016-08-1116:42 ET | 10-Q | Quarterly reportPeriod 2016-06-30 | 0001558370-16-007925 |
| 2016-08-1016:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-16-138633 |
| 2016-06-1317:00 ET | 8-K | 5.07 Shareholder vote results | 0001104659-16-126883 |
| 2016-05-1217:16 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-16-120531 |
| 2016-05-1108:40 ET | 10-Q | Quarterly reportPeriod 2016-03-31 | 0001558370-16-005855 |
| 2016-05-1016:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-16-119722 |
| 2016-04-2917:00 ET | DEF 14A | Proxy statementPeriod 2016-06-09 | 0001047469-16-012758 |
| 2016-04-1517:00 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001104659-16-111872 |
| 2016-03-2414:03 ET | SC 13D | Ownership report, active investor | 0001193125-16-516587 |
| 2016-03-1817:08 ET | 10-K | Annual reportPeriod 2015-12-31 | 0001558370-16-004252 |
| 2016-03-1616:59 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-16-105513 |
| 2016-01-2610:25 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-16-091368 |
| 2016-01-0416:45 ET | S-1/A | Registration statement, amended | 0001047469-16-009528 |
| 2016-01-0406:47 ET | S-1/A | Registration statement, amended | 0001047469-16-009501 |
| 2015-12-2806:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-15-086798 |
| 2015-12-1817:17 ET | S-1 | Registration statement | 0001047469-15-009318 |
| 2015-11-1216:02 ET | 10-Q | Quarterly reportPeriod 2015-09-30 | 0001558370-15-002623 |
| 2015-11-1210:51 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-15-078112 |
| 2015-08-1318:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-15-059205 |
| 2015-08-1217:01 ET | 10-Q | Quarterly reportPeriod 2015-06-30 | 0001104659-15-059155 |
| 2015-08-1017:22 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-15-058331 |
| 2015-07-1716:01 ET | 10-Q/A | Quarterly report, amendedPeriod 2015-03-31 | 0001104659-15-051689 |
| 2015-07-1707:01 ET | 10-Q/A | Quarterly report, amendedPeriod 2015-03-31 | 0001104659-15-051548 |
| 2015-06-2217:22 ET | 10-Q | Quarterly reportPeriod 2015-03-31 | 0001104659-15-046731 |
| 2015-06-1916:17 ET | 8-K | 8.01 Other events | 0001104659-15-046449 |
| 2015-05-2116:02 ET | SC 13D | Ownership report, active investor | 0001144204-15-032917 |
| 2015-05-2016:09 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-15-039656 |
| 2015-05-1216:31 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-15-037290 |
| 2015-04-2706:10 ET | S-1/A | Registration statement, amended | 0001047469-15-003920 |
| 2015-04-0216:52 ET | S-1 | Registration statement | 0001047469-15-003143 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 10, 2026, 23:07 ET. Listed shows no prices and gives no investment advice.